IRVINE, Calif.–(BUSINESS WIRE)–Jul. 14, 2016–
Masimo
(NASDAQ: MASI) announced today that in a new study using the 1st
Generation Masimo Pronto® Pulse CO-Oximeter®,
which noninvasively measures total hemoglobin (SpHb®),
researchers found that noninvasive and invasive measurements correlated
well and that “[g]iven the rapid availability of results and the lack of
requirement of venipuncture, noninvasive hemoglobin monitoring may be a
valuable adjunct in the initial evaluation and monitoring of pediatric
trauma patients.”1
Pronto features rainbow SET™ technology, allowing for the noninvasive
spot checking of…
Más información: New Study Assesses Utility of 1st Generation Masimo Pronto® Pulse CO-Oximeter® with SpHb® Spot Check Technology in Evaluating Pediatric Trauma Patients